Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VRX

Valeant

$22.10

-0.6 (-2.64%)

07:21
01/19/18
01/19
07:21
01/19/18
07:21
Recommendations
Valeant analyst commentary at Wells Fargo »

Market overlooking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 18

    Jun

  • 27

    Aug

Tuesday
VRX

Valeant

$22.98

-0.86 (-3.61%)

, AGN

Allergan

$178.66

2.61 (1.48%)

16:58
01/16/18
01/16
16:58
01/16/18
16:58
Periodicals
Judge may clear $290M settlement between Allergan holders, Valeant, WSJ says »

A federal judge indicated…

VRX

Valeant

$22.98

-0.86 (-3.61%)

AGN

Allergan

$178.66

2.61 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 13

    Feb

  • 16

    Feb

  • 25

    Mar

  • 18

    Jun

  • 27

    Aug

VRX

Valeant

$22.95

-0.8911 (-3.74%)

15:02
01/16/18
01/16
15:02
01/16/18
15:02
Recommendations
Valeant analyst commentary at Wells Fargo »

Valeant settlement put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 18

    Jun

  • 27

    Aug

VRX

Valeant

$23.84

0.03 (0.13%)

07:25
01/16/18
01/16
07:25
01/16/18
07:25
Recommendations
Valeant analyst commentary at H.C. Wainwright »

Valeant price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 18

    Jun

  • 27

    Aug

Over a week ago
VRX

Valeant

$23.81

0.38 (1.62%)

07:04
01/12/18
01/12
07:04
01/12/18
07:04
Hot Stocks
Ortho Dermatologics: FDA accepts NDA for IDP-121 »

Ortho Dermatologics, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

VRX

Valeant

$23.69

-0.181 (-0.76%)

13:54
01/10/18
01/10
13:54
01/10/18
13:54
Hot Stocks
Breaking Hot Stocks news story on Valeant »

Valeant sees Bausch +…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 18

    Jun

VRX

Valeant

$23.63

-0.24 (-1.01%)

13:50
01/10/18
01/10
13:50
01/10/18
13:50
Hot Stocks
Valeant will increase dermatology sales force, reallocate towards psoriasis »

"Based on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 18

    Jun

VRX

Valeant

$23.70

-0.17 (-0.71%)

13:47
01/10/18
01/10
13:47
01/10/18
13:47
Hot Stocks
Valeant CEO says dermatology business has been a 'challenge' »

During the presentation,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 18

    Jun

VRX

Valeant

$23.65

-0.22 (-0.92%)

13:39
01/10/18
01/10
13:39
01/10/18
13:39
Hot Stocks
Breaking Hot Stocks news story on Valeant »

Valeant CEO: Gaining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 18

    Jun

VRX

Valeant

$23.65

-0.225 (-0.94%)

, AGN

Allergan

$172.89

-2.76 (-1.57%)

13:37
01/10/18
01/10
13:37
01/10/18
13:37
Hot Stocks
Valeant paid down $6.5B of debt since end of 1Q16 »

Settled 70 legal cases…

VRX

Valeant

$23.65

-0.225 (-0.94%)

AGN

Allergan

$172.89

-2.76 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 06

    Feb

  • 16

    Feb

  • 25

    Mar

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.